1089 related articles for article (PubMed ID: 18311801)
1. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
[TBL] [Abstract][Full Text] [Related]
2. What is the rank of RANKL in spondylarthritis?
Loddenkemper K; Burmester GR
Arthritis Rheum; 2008 Mar; 58(3):641-4. PubMed ID: 18311809
[No Abstract] [Full Text] [Related]
3. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
[TBL] [Abstract][Full Text] [Related]
4. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
Kotake S; Udagawa N; Hakoda M; Mogi M; Yano K; Tsuda E; Takahashi K; Furuya T; Ishiyama S; Kim KJ; Saito S; Nishikawa T; Takahashi N; Togari A; Tomatsu T; Suda T; Kamatani N
Arthritis Rheum; 2001 May; 44(5):1003-12. PubMed ID: 11352231
[TBL] [Abstract][Full Text] [Related]
5. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM; Nishioka K; Yudoh K
Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
[TBL] [Abstract][Full Text] [Related]
6. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
Tunyogi-Csapo M; Kis-Toth K; Radacs M; Farkas B; Jacobs JJ; Finnegan A; Mikecz K; Glant TT
Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542
[TBL] [Abstract][Full Text] [Related]
8. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
9. Disease-specific and inflammation-independent stromal alterations in spondylarthritis synovitis.
Yeremenko N; Noordenbos T; Cantaert T; van Tok M; van de Sande M; Cañete JD; Tak PP; Baeten D
Arthritis Rheum; 2013 Jan; 65(1):174-85. PubMed ID: 22972410
[TBL] [Abstract][Full Text] [Related]
10. Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: quantification using color video image analysis.
Crotti TN; Ahern MJ; Lange K; Weedon H; Coleman M; Roberts-Thomson PJ; Haynes DR; Smith MD
J Rheumatol; 2003 Nov; 30(11):2319-24. PubMed ID: 14677171
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts.
Kubota A; Hasegawa K; Suguro T; Koshihara Y
J Rheumatol; 2004 Mar; 31(3):426-35. PubMed ID: 14994384
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha drives cadherin 11 expression in rheumatoid inflammation.
Vandooren B; Cantaert T; ter Borg M; Noordenbos T; Kuhlman R; Gerlag D; Bongartz T; Reedquist K; Tak PP; Baeten D
Arthritis Rheum; 2008 Oct; 58(10):3051-62. PubMed ID: 18821672
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis.
Noordenbos T; Yeremenko N; Gofita I; van de Sande M; Tak PP; Caňete JD; Baeten D
Arthritis Rheum; 2012 Jan; 64(1):99-109. PubMed ID: 21968742
[TBL] [Abstract][Full Text] [Related]
15. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
[TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand mRNA expression in patients with rheumatoid arthritis and healthy controls.
Vanderborght A; Linsen L; Thewissen M; Geusens P; Raus J; Stinissen P
J Rheumatol; 2004 Aug; 31(8):1483-90. PubMed ID: 15290725
[TBL] [Abstract][Full Text] [Related]
17. RANK ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse.
Mori H; Kitazawa R; Mizuki S; Nose M; Maeda S; Kitazawa S
Histochem Cell Biol; 2002 Mar; 117(3):283-92. PubMed ID: 11914926
[TBL] [Abstract][Full Text] [Related]
18. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
Vandooren B; Noordenbos T; Ambarus C; Krausz S; Cantaert T; Yeremenko N; Boumans M; Lutter R; Tak PP; Baeten D
Arthritis Rheum; 2009 Apr; 60(4):966-75. PubMed ID: 19333931
[TBL] [Abstract][Full Text] [Related]
19. Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis.
Makrygiannakis D; af Klint E; Catrina SB; Botusan IR; Klareskog E; Klareskog L; Ulfgren AK; Catrina AI
Arthritis Rheum; 2006 May; 54(5):1463-72. PubMed ID: 16646024
[TBL] [Abstract][Full Text] [Related]
20. Synovial fibroblasts promote osteoclast formation by RANKL in a novel model of spontaneous erosive arthritis.
Wu Y; Liu J; Feng X; Yang P; Xu X; Hsu HC; Mountz JD
Arthritis Rheum; 2005 Oct; 52(10):3257-68. PubMed ID: 16200600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
